Jacqueline W. K. Wu

Jacqueline W. K. Wu

Auto-generated profile, based on publicly available information

Jacqueline W. K. Wu

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2025 in Science Advances
Verified
Journal Article
Open access
JWJessica A. Wojick
Jessica A. Wojick
APAlekh Paranjapye
Alekh Paranjapye
JCJuliann K. Chiu
Juliann K. Chiu
COCorinna S. Oswell
Corinna S. Oswell
MMMalaika Mahmood
Malaika Mahmood
GCGregory Corder
Gregory Corder
The basolateral amygdala (BLA) assigns valence to sensory stimuli, with a dedicated nociceptive ensemble encoding the negative valence of pain. However, the effects of chronic pain on the transcriptomic signatures and projection architecture of this BLA nociceptive ensemble are not well understood. Here, we show that optogenetic inhibition of the nociceptive BLA ensemble reduces affective-motivational behaviors in chronic neuropathic pain. Single-nucleus RNA sequencing revealed peripheral injury–induced changes in genetic pathways involved in axonal and presynaptic organization in nociceptive BLA neurons. Next, we identified a previously uncharacterized nociceptive hotspot in the nucleus accumbens shell that is innervated by BLA nociceptive neurons. Axonal calcium imaging of BLA projections to the accumbens and chemogenetic inhibition of this pathway revealed pain-related transmission from the amygdala to the medial nucleus accumbens, facilitating both acute and chronic pain affective-motivational behaviors. Together, this work defines a critical nociceptive amygdala-striatal circuit underlying pain unpleasantness across pain states.

31 July 2025 in bioRxiv
Verified
Preprint
Open access
SCSavanna A. Cohen
Savanna A. Cohen
LWLisa M. Wooldridge
Lisa M. Wooldridge
JJJustin J. James
Justin J. James
JWJacqueline W. K. Wu
Jacqueline W. K. Wu
GCGregory F. Corder
Gregory F. Corder
Understanding opioid withdrawal behaviors in preclinical models is critical to improving therapeutic approaches for opioid use disorder (OUD). However, quantifying these withdrawal behaviors remains a difficult process for researchers, given the subtlety of behaviors and variation across individuals. To overcome these difficulties, we developed a scalable behavioral analysis pipeline using LUPE (Light aUtomated Pain Evaluator), an open-source framework integrating video acquisition, pose estimation, supervised and unsupervised classification, and expert-guided behavior discovery. Mice undergoing naloxone-precipitated opioid withdrawal were recorded and analyzed using DeepLabCut for markerless pose estimation. We hand-annotated withdrawal-specific behaviors, including jumping, genital licking, grooming, and paw tremors, and normal behaviors, including walking, rearing, and being still, using Behavioral Observation Research Interactive Software (BORIS) to generate frame-by-frame ethograms. The annotations and pose data were then imported into Active learning Segmentation of Open field in DeepLabCut (A-SOiD), an active learning platform for behavior classification. A-SOiD successfully detected some behaviors (e.g., grooming and rearing) which were of a longer duration, though other rapid behaviors (e.g., jumping and paw tremors) were inconsistently captured. While no novel behavioral motifs have been discovered yet, ongoing work aims to refine model performance. This LUPE-based pipeline sets the groundwork for standardized, high-resolution behavior quantification and is being applied to additional datasets to investigate whether new components of the withdrawal phenotype emerge across experimental conditions.

19 December 2025 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
LWLisa M. Wooldridge
Lisa M. Wooldridge
JWJacqueline W. K. Wu
Jacqueline W. K. Wu
AJAdrienne Y. Jo
Adrienne Y. Jo
MZMorgan Zinn
Morgan Zinn
ALAngela M. Lee
Angela M. Lee
GCGregory Corder
Gregory Corder
Aversion to opioid withdrawal is a significant barrier to achieving lasting opioid abstinence. The central amygdala (CeA), a key brain region for pain, threat-detection, autonomic engagement, and valence assignment, is active during opioid withdrawal. However, the role of molecularly distinct CeA neural populations in withdrawal remains underexplored. Here, we investigated the activity dynamics, brain-wide connectivity, and functional contribution of Protein Kinase C-delta (PKCδ)-expressing neurons in the CeA lateral capsule (CeLC PKCδ ) during fentanyl withdrawal in mice. Mapping activity-dependent gene expression in CeLC PKCδ neurons revealed a highly withdrawal-active subregion in the anterior half of the CeA. Fiber photometry calcium imaging showed that opioid-naïve CeLC PKCδ neurons respond to salient noxious and startling stimuli. In fentanyl-dependent mice, naloxone-precipitated withdrawal increased spontaneous neural activity and enhanced responses to noxious stimuli. Chronic inhibition of CeLC PKCδ neurons throughout fentanyl exposure, via viral overexpression of the potassium channel Kir2.1, attenuated withdrawal symptoms in fentanyl-dependent mice. Lastly, we identified putative opioid-sensitive inputs to CeLC PKCδ neurons using rabies-mediated monosynaptic circuit tracing and color-switching tracers to map mu-opioid receptor-expressing inputs to the CeLC. Collectively, these findings suggest that the hyperactivity of CeLC PKCδ neurons underlies the somatic signs of fentanyl withdrawal, offering new insights into the amygdala cell-types and circuits involved in opioid dependence.